Orexigen Therapeutics Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, Friday announced the appointment of David Endicott to its board of directors.
3344 North Torrey Pines Ct. Ste., 200
La Jolla, CA 92037
All contents herein copyright San Diego Source | The Daily Transcript ® 1994-2015